0 results for 'Monsanto'
How Proskauer's Bart Williams Helped Land a Defense Verdict in Gilead Pay-for-Delay Antitrust Case
"In antitrust cases, because these are such blockbuster drugs, the numbers are even higher, so the financial stakes are even higher, which is why many of the so-called 'pay-for-delay' cases settle," says Proskauer's Bart Williams, a finalist for the California Legal Awards' Attorney of the Year award.'Not a Fluke': Plaintiffs Lawyers See Changing Tide in $175M Roundup Verdict
"Their defense collapses when the plaintiffs lawyers can show that the epidemiology and the science and the medicine support a finding that there is, in fact, causation," Thomas Kline said.Plaintiffs Notch $175M Win in Philadelphia's First Roundup Trial
The verdict consisted of $25 million in compensatory damages and $150 million in punitive damages.Monsanto's Roundup Winning Streak Ends With $1.25M Verdict
Friday's verdict by a jury in St. Louis, Missouri, was the first jury award for a Roundup plaintiff since before the COVID-19 pandemic and ends Monsanto's nine-trial winning streak.View more book results for the query "Monsanto"
The Significant Impact of Interest Taxation as a Settlement Valuation Bridge (Nationally)
In personal injury claims where the two sides have disparate valuations based in part on substantial interest accrual, there exists an underused tool for bridging the difference and reaching an accord.Philadelphia Roundup Trial Kicks Off With Claims of Additional 'Problem Chemical'
Thomas Kline of Kline & Specter, making his opening statement for the plaintiff, argued that Roundup's alleged cancer-causing properties are rooted in more than just its active ingredient.In Trial Openings, Plaintiffs Present New Allegations About 'What's Really in the Bottle of Roundup'
Plaintiffs' lawyers focused on more than glyphosate, the active ingredient in Monsanto's Roundup, in attempting to convince jurors in two separate trials that the pesticide causes cancer.PFAS Claim Against Chemical Giants Survives Motion to Dismiss in Maine Federal Court
"Defendant 3M conducted studies in the 1950s and early 1960s that showed its perfluorooctanesulfonate (PFOS) accumulates in the human body and is toxic," stated U.S. Magistrate Judge John C. Nivison, in his written opinion for the court. "By the 1970s, additional 3M studies revealed that its PFOS products were 'even more toxic' than previously believed.Corporate Transparency Act Resource Kit
Brought to you by Wolters Kluwer
Download Now
Revenue, Profit, Cash: Managing Law Firms for Success
Brought to you by Juris Ledger
Download Now
Law Firm Operational Considerations for the Corporate Transparency Act
Brought to you by Wolters Kluwer
Download Now
The Ultimate Guide to Remote Legal Work
Brought to you by Filevine
Download Now